Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Genetic changes in ATM and ATR/CHEK1 as prognostic indicators in cancer

Genetic changes in ATM and ATR/CHEK1 as prognostic indicators in cancer

US Patent 8173366 · Granted May 8, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for inhibiting fascin2025
Subnetwork selection2025
Compounds and methods for inhibiting fascin2024
Transaminase mutant and use thereof2024
Methods for inhibiting fascin2024
Compounds and methods for inhibiting fascin2024
Proline hydroxylase and uses thereof2023
Co-therapies including a metastasis inhibitor2023
Transaminase mutant and application thereof2022
Proline hydroxylase and uses thereof2021
Compounds and methods for inhibiting fascin2021
Methods for inhibiting fascin2021